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Open access under the ElGroup A rotaviruses (RVA) is the most important cause of severe gastroenteritis among children world-
wide. Vaccination is considered the best alternative among public health measures to reduce and prevent
the global burden caused by RVA infections. Rotarix™, a monovalent vaccine based on a human strain
with a G1P[8]-1 speciﬁcity, was introduced in the National Brazilian Immunization Programs (NIP) in
March, 2006. RVA P[8] is the most prevalent P genotype worldwide and four distinct phylogenetic lin-
eages: P[8]-1, -2, -3, and -4 have been described. In the current study phylogenetic analysis of the
VP8⁄ gene of 135 RVA P[8] Brazilian strains, in combination with G1, G3, G5 or G9 VP7 genotype, collected
from 1986 to 2011 were carried out for a better understanding of the evolution of this viral genotype in
Brazil. Lineages P[8]-1, P[8]-2, and P[8]-3 were observed circulating in Brazil. In 2001 these three P[8] lin-
eages co-circulated simultaneously and this is the ﬁrst report in South America to date. Considering the
P[8] lineage and the G genotype, all G3 strains were related to lineage P[8]-3, whereas the G9 strains were
related to P[8]-2 and P[8]-3 and G1 and G5 were related to P[8]-1, P[8]-2, and P[8]-3. In addition, the phy-
logenetic analysis based on estimate of genetic distances between P[8]-3 strains and the deﬁnition of a
1.5% cutoff value (with relevant statistical support) it was possible to propose a new classiﬁcation for
the P[8]-3 lineage into six different sub-lineages: P[8]-3.1 to P[8]-3.6. These ﬁndings reinforce the notion
of the existence of constraints within speciﬁc RVA strains populations. The results obtained in this study
reinforce the importance of a continuous RVA surveillance of circulating strains in order to predict the
possible variants that will circulate in a country, assess the effects of vaccination on RVA circulating
strains, and ultimately help in the design, challenges, and prospects of RVA vaccines.
 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Group A rotaviruses (RVA) are the leading cause of severe gas-
troenteritis among children, accounting for approximately one
third of total diarrhea deaths worldwide (Tate et al., 2010). RVA
genome consists of 11 double-stranded RNA (dsRNA) segments,
encoding ﬁve (or six) nonstructural proteins (NSPs) and six struc-
tural proteins (VPs) (Estes and Kapikian, 2007), surrounded by a
triple-layered protein capsid. Based on antigenic and genetic
differences of two viral surface proteins, VP4 and VP7, RVA can
be classiﬁed into P (Protease sensitive) and G (Glycolyslated)irologia Comparada e Ambi-
ruz, FIOCRUZ, Avenida Brasil
l. Tel.: +55 21 25621923; fax:
Silva).
sevier OA license.genotypes, respectively. So far, 27 G and 35 P genotypes have been
identiﬁed in humans as well as in different animals (Matthijnssens
and Van Ranst, 2012).
Mechanisms that promote RVA diversiﬁcation include point
mutations, intersegmental recombination, rearrangements, reas-
sortment, and interspecies transmission (Desselberger, 1996; Itur-
riza-Gomara et al., 2000; Estes and Kapikian, 2007; Heiman et al.,
2008). Point mutations and reassortments are frequently described
for RVA and can eventually lead to the emergence of RVA strains
that escape neutralization by speciﬁc antibodies. Five binary G/P
genotype combinations (G1P[8], G3P[8], G4P[8], G9P[8], and
G2P[4]) are responsible for more than 90% of human RVA cases de-
tected around the world (Matthijnssens and Van Ranst, 2012). In
Brazil, G1-G4 account for 65% of strains but the atypical G5was also
observed (Leite et al., 2008). In order to achieve efﬁcient cell entry,
the VP4 protein is cleaved by trypsin into a N-terminal fragment
(VP8⁄) and a C-terminal fragment (VP5⁄) (Espinola et al., 2008).
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tralization domains deﬁned by amino acid alignments andmapping
of monoclonal antibody escape mutants (Kirkwood et al., 1996).
Studies demonstrated antigenic and genomic variations inside the
VP8⁄ region, especially among strains bearing G1–G4 and G9 geno-
types in association with P[8], which represent the most prevalent
genotypes in humans and are the main targets for vaccine studies.
So far, studies on the VP8⁄ fragment of P[8] genotype have shown
four distinct phylogenetic lineages circulating worldwide: P[8]-1,
-2, -3, and -4 (Arista et al., 2006; Cunliffe et al., 2001).
Rotarix™, a monovalent vaccine based on a human strain with
G1P[8] (P[8]-1) speciﬁcity, was introduced in the National Brazil-
ian Immunization Programs (NIP) in March, 2006. In the present
report the genetic variation of P[8] genotype of human RVA strains
circulating in Brazil between 1986 and 2011 is described through
analysis of 135 RVA strains from vaccinated and non vaccinated
children living in 4 out of the 5 Brazilian regions. In addition, a pro-
posal to classify the P[8]-3 lineage into six different sub-lineages:
P[8]-3.1 to P[8]-3.6 based on phylogenetic analysis results, is
presented.2. Materials and methods
2.1. Study population
The stool samples were randomly selected from a pool of RVA
positive patients, in order to uniformly represent all the study per-
iod and all geographic regions involved. Aiming to avoid selection
bias, when more than one positive sample was provided by city
and year, the same proportion of them were randomly selected
from the pool of available samples, reaching thus the ﬁnal sum
of 135 patients (44 G1P[8], 21 G3P[8], 28 G5P[8] and 42 G9P[8])
obtained from children with acute diarrhea living in 4 out of the
5 Brazilian regions: Northern, Northeastern, Southeastern, and
Southern between 1986 and 2011. Of the 44 G1P[8] strains, 19
were collected from children vaccinated with one or two doses of
Rotarix™. This study was approved by the Institutional Research
Ethics Committee (CEP-FIOCRUZ 311/06). The accession numbers
of the nucleotide sequences are available in the Supplementary
Material.
2.2. Nucleic acid puriﬁcation, ampliﬁcation and sequencing
Nucleic acids were extracted by the glass powder method
(Boom et al., 1990) with modiﬁcations described by Leite et al.Fig. 1. P[8] lineages chronology in Brazil from 1986 to 2011. The products of the cleava(1996). The viral dsRNA was reverse transcribed (RT) and the prim-
ers used for ampliﬁcation of VP8⁄ gene were designed to generate
an amplicon of 887 bp from the 50 terminus of the gene (Gentsch
et al., 1992). The VP8⁄ primers, used to obtain the RT-PCR ampli-
con, were employed individually for gene sequencing. Forward
and reverse strand ampliﬁcation reaction was carried out for each
sequence obtained at least twice. DNA sequencing was performed
with an ABI Prism Big Dye Terminator Cycle Sequencing Ready
Reaction Kit and an ABI Prism 3730 Genetic Analyzer (both from
Applied Biosystems, Foster City, CA, USA) by Genomic Platform of
DNA sequencing PDTIS/FIOCRUZ. All procedures to avoid cross-
contamination were performed, including negative controls
(DNase/RNase free water – Gibco, Grand Island, USA – with RNase-
Out – Invitrogen, Carlsbad, USA), during all steps.
2.3. Phylogenetic and genetic distance analyses
Mean nucleotide distances within and among different P[8] lin-
eages and sub-lineages were estimated using the Tamura-Nei
model (Tamura and Nei, 1993) as implemented in MEGA 4 v.4.0
software package (Tamura et al., 2007). Mean nucleotide distances
between P[8]-3 sub-clusters were P.017, while mean nucleotide
distances within P[8]-3 sub-clusters were 60.012. Thus, based on
genetic distance results, it was proposed a cutoff value of 1.5% to
deﬁne distinct P[8]-3 sub-lineages.3. Results and discussion
To evaluate the genetic diversity of RVA strains circulating in a
country considering evolutionary forces involved are important is-
sues in studies of anti-RVA vaccines. In order to reach a better
understanding of how these forces act, numerous studies have
investigated the genetic variation of the P[8] genotype worldwide
(Arista et al., 2006, Espinola et al., 2008; Iturriza-Gomara et al.,
2000; Stupka et al., 2012).
A total of 135 RVA P[8] strains belonging to VP7 genotypes: G1,
G3, G5, and G9 were sequenced in order to evaluate the evolution-
ary relationships between the P[8] lineages of human RVA detected
in Brazil before and after Rotarix™ introduction in the NIP in com-
parison with human and animal RVA strains detected worldwide.
The results presented here demonstrate that P[8]-1, P[8]-2, and
P[8]-3 lineages were detected in Brazil in the last 25 years. Fig. 1
shows the chronology of the three P[8] lineages detected in Brazil
over the studied period. To our knowledgment, these lineages are
preserved overtime and in different countries (Espinola et al.,ge of the protein VP4 (VP5 ⁄ and VP8 ⁄) are actually represented with the symbol ⁄.
Fig. 2. Phylogenetic analysis of nucleotide sequence of VP8 encoding gene of Brazilian P[8] RVA strains described in this study showing the distribution of lineages P[8]-1,
P[8]-2 and P[8]-3. Bootstrap values above 75%, estimated with 2000 pseudoreplicate data sets, are indicated at the key nodes.
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lineage could not be detected in the present report, which is con-
sistent with previous studies carried out in South America (Araújo
et al., 2007; Espinola et al., 2008; Tort et al., 2010). Phylogenetic
analysis of the VP8⁄ gene demonstrate that Brazilian RVA P[8]
strains clustered into three distinct evolutionary lineages: P[8]-1
(n = 16), P[8]-2 (n = 27), and P[8]-3 (n = 92) (Fig. 1). The co-circula-
tion of distinct P[8] lineages was observed throughout the study,
particularly in 2001, when the lineages P[8]-1, P[8]-2 and P[8]-3
were detected co-circulating simultaneously in Brazil and this is
the ﬁrst report of such an event in South America. Although this
phenomenon was described in other regions including the United
Kingdom (P[8]-1/P[8]-2/P[8]-3) (Iturriza-Gomara et al., 2000,
2001) and Malawi (P[8]-2/P[8]-3/P[8]-4) (Cunliffe et al., 2001),
the co-circulation of P[8] -1, 2 and 3 seems to be quite rare in Bra-
zil, since in the 25-year period studied (1986–2011) was only
found in 2001. The co-circulation of 2 lineages was detected in
7 years (P[8]-1 and P[8]-2 in 1992; P[8]-1 and P[8]-3 in 1996,
1998, 2002, 2005, 2008 and 2010) and the detection of only one
lineage in 11 years (P[8]-1 in 1992; P[8]-2 in 1986, 1987, 1988
and 1990 and P[8]-3 in 2003, 2004, 2006, 2007, 2009 and 2011)
(Fig. 1). Up to now, there are no studies reporting the co-circulation
of these four P[8] lineages, suggesting that the appearance and dis-
appearance of different P[8] lineages might be a mechanism that
helps RVA to escape from the immunity developed by the popula-
tion due to previous infections (Espinola et al., 2008).
The P[8]-1 lineage contains eleven G5 and ﬁve G1 Brazilian
strains collected in the 1990’s and in the 2000s, respectively,
including three G1 strains from vaccinated children collected in
2009 and 2010 (Fig. 2). This clade also contains one G1 Paraguayan
strain (EU045238), the prototype strains isolated in the 1970’s
(Wa-genotype G1, DC5751 and DC2171-genotype G3, DC5115-
genotype G4), the genotype G1 strain BE0048 collected in 2009
in Belgium and G1 Rotarix™ vaccine strain RIX4414. The mean
nucleotide distance among P[8]-1 strains was of 0.034 (Table 1).
The comparative alignment analysis demonstrated the high genet-
ic heterogeneity among the sequences (Supplementary Material 2).
The alignment of the deduced amino acid sequences of VP8⁄ re-
vealed amino acid substitutions in many regions: 38V ? I, 41S ? G,
67M ? I, 123T ? M, 124V ? I, 128N ? S, 134R ? S, 138D ? N, 166F ? L,
170F ? L, 176I ? V, 192N ? S, 194A ? T, 198D ? N and 202I ? T. Further
studies will be needed to determine the potential effects of the
substitution changes in the P[8]-1sequences identiﬁed in this
study.
The P[8]-2 lineage consists of 16 G5 Brazilian strains detected in
Brazil in the 1980/1990’s, eight G1 Brazilian strain collected be-
tween 1986 and 1991 and three G9 Brazilian strains collected in
2001, besides prototype strains from different countries, genotype
speciﬁcity and year of isolation include: Brazil- G5 IAL28, H8, and
1054; Malawi- G3 MW258; USA- G1 KU; and Paraguay- G1 Py9856
(Fig. 2). The mean nucleotide distance among P[8]-2 strains was of
0.03 (Table 1).Table 1
Mean nucleotide distances in VP8⁄ gene within (intra-sublineage) and among (inter-
sublineage) P[8]-3 lineage.
P[8]-3.1 P[8]-3.2 P[8]-3.3 P[8]-3.4 P[8]-3.5 P[8]-3.6
P[8]-3.1 0.012
P[8]-3.2 0.020 0.009
P[8]-3.3 0.026 0.025 0.003
P[8]-3.4 0.017 0.019 0.021 0.009
P[8]-3.5 0.028 0.027 0.030 0.020 0.002
P[8]-3.6 0.033 0.034 0.035 0.024 0.025 0.006
Mean intra-sublineage (bold) and inter-sublineage nucleotide distances estimated
by the Tamura Nei model with 2000 replicates using MEGA 5 program.The alignment of the deduced amino acid sequences of P[8]-2
revealed few amino acid substitutions in the Brazilian strains over
the time: 85SN and 191AT showing the high conservation of this
lineage (Supplementary Material 2b).
Most Brazilian strains grouped within the P[8]-3 lineage which
includes several strains circulating worldwide, corroborating pre-
vious studies (Espinola et al., 2008; Parra et al., 2009). This lineage
was ﬁrst detected in Brazil in a G5 strain collected in Rio de Janeiro
in 1996 and remained detected until this date (Silva et al., 2011).
P[8]-3 was the unique P[8] lineage detected circulating in Brazil
after 2005, with the exception of the three P[8]-1 strains collected
from vaccinated children. Within this lineage strains bearing VP7
genotypes were detected G1, G3, G5 and G9, collected from 1996
to 2011 in four different Brazilian regions: Northern (States of Acre
and Rondônia), Northeastern (States of Alagoas, Bahia, Maranhão,
Pernambuco, and Sergipe), Southern (State of Rio Grande do Sul)
and Southeastern (States of Espírito Santo and Rio de Janeiro)
(Fig. 2). It is noteworthy that G3 associated with P[8]-3 was only
detected in Brazil. In the same cluster, RVA prototype strains from
different countries bearing distinct VP7 genotypes were grouped as
such G1, G3, G8, and G12. The mean nucleotide distance among
P[8]-3 strains was of 0.021 (Table 1).
As displayed in Table 1, mean nucleotide distances between
P[8]-3 sub-clusters wereP0.017, while mean nucleotide distances
within P[8]-3 sub-clusters were 60.012. Thus, the deﬁnition of a
1.5% cutoff value was established to propose a new classiﬁcation
for the P[8]-3 lineage into six different sub-lineages, here named
P[8]-3.1 to P[8]-3.6 (Fig. 3). The sub-lineage P[8]-3.1 was the most
prevalent in Brazil over the last years and comprises strains of dis-
tinct VP7 genotypes (G1, G3 and G9) collected from 2002 to 2010,
and includes several prototype strains detected worldwide during
the 2000s. The sub-lineage P[8]-3.1 comprises RVA prototypes de-
scribed worldwide: Australia, Bangladesh, Democratic Republic of
Congo, Pakistan, and Paraguay; G3 and G9 Brazilian strains circu-
lating in Rio de Janeiro between 2002 and 2007 and G1 Brazilian
strains circulating in Bahia in 2004 and Maranhão in 2010. The
sub-lineage P[8]-3.2 only comprises G9 Brazilian strains circulating
in Rio de Janeiro and Acre between 1998 and 2006. It was exclu-
sively associated to G9 strains collected in Rio de Janeiro (South-
east region) from 1998 to 2003 and in Acre (North region) in
2006, consistent with previous ﬁndings (Tort et al., 2010). The
sub-lineage P[8]-3.3 comprises several Brazilian strains of distinct
VP7 genotypes including: 2 G1 and 4 G9 strains collected in Rio de
Janeiro in 2003, one G1 strain collected in Espírito Santo in 2008
and 10 G3 strains collected in different Brazilian regions. This
sub-lineage also comprises three prototypes described in Russia
(Nov09-D182), Australia (CK00029), and at the United States of
America (VU06-07-27). The sub-lineage P[8]-3.4 comprises Brazil-
ian strains bearing G5, G1, and G9 genotypes, collected in Rio de Ja-
neiro in 1996, 2001 and 2003, respectively. No prototype strains
were grouped in this sub-lineage. The sub-lineage P[8]-3.5 in-
cludes G1 Brazilian strains collected in the Northeastern Brazil in
2009 and 2010 – both from vaccinated children – and prototype
strains collected in Russia in 2004 and 2007 (Nov04-H578 and
Omsk07-217). As shown in the P[8]-3.2 analysis, P[8]-3.5 seems
to display a restricted pattern of circulation as it only comprises
G1 Brazilian strains collected in the northeast of Brazil in 2009
and 2010. The sub-lineage P[8]-3.6 consist of one G9 strain col-
lected in the Northern (State of Rondônia) in 2006 and several
G1 strains obtained from vaccinated children in 2009 in the north-
east of Brazil (State of Sergipe), together with prototype strains
from Paraguay, Russia and Belgium. It is important to emphasize
that the sub-lineages P[8]-3.5 and P[8]-3.6 were detected circulat-
ing in Brazil only after the introduction of Rotarix™. Analysis of lar-
ger datasets of Brazilian and non-Brazilian RVA P[8]-3 strains will
be of paramount importance to resolve this question.
Fig. 3. Phylogenetic analysis of nucleotide sequence of VP8⁄ encoding gene of Brazilian P[8] RVA strains showing the six P[8]-3 sub-lineages. Bootstrap values above 75%,
estimated with 2000 pseudoreplicate data sets, are indicated at the key nodes.
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3 strains revealed amino acid substitutions in the sequences over
the time in some positions, as shown in the Supplementary Mate-
rial 2.c: 78T ? S/A, 85N ? T, 91V ? I, 104A ? I, 113N ? D/G, 147S ? N,
149N ? T, 169Y ? H, 173I ? V, 184T ? I and 194N ? D, although more
analyses showing the effects of these substitutions observed in
the lineages/sub-lineages are needed to better understand RVA
P[8]-3 evolution in Brazil.
This work contributes for a better understanding of the dynam-
ics and pattern of P[8] dispersion into different lineages/sub-lin-
eages and their association with G genotypes in Brazil. Both RVA
licensed vaccine, Rotarix™ and Rotateq™, include genotype P[8]
in their formulation. However, new P[8] variants less affected by
vaccine induced immunity and can emerge as the result of one,
or more evolutionary mechanisms that shape RVA evolution. Con-
sequently, a continuous surveillance of RVA strains is needed in or-
der to predict potential variants that may circulate and also to
improve current vaccination programs.
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